Fracture Prevention
📧 Sign up to get email alerts when something new happens for Fracture Prevention.
Sign up freeTop drugs studied for this disease
-
EMA label_change · 2012-03-16European Medicines Agency confirms positive benefit-risk balance of Protelos / Osseor, but recommends new contraindications and revised warnings
The EMA confirms a positive overall benefit-risk for Protelos/Osseor but recommends new contraindications and revised warnings.